Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Abivax, Astellas, Bone, Glenmark, I-Mab, JHL, Kaleido, Moderna, Neurorx, Oryzon Genomics, Relief, Roivant Sciences, Samsung Bioepis, Taiwan Liposome, Zai Lab.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Athersys, Biontech, Calcimedica, Cytodyn, Daewoong, Eli Lilly, Enlivex, Hightide, Humanigen, Innovent Biologics, Kiniksa, Mesoblast, Noxopharm, Pfizer, Rising.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Aridis, Athersys, Biontech, Calcimedica, Chimerix, Cromos, Eiger, Eli Lilly, Geneone Life Science, Gilead Sciences, Gracell, I-Mab, Innate, Innovent, Inovio, Janssen, Lupin, Mesoblast, Morphosys, Novartis, Pfizer, R-Pharm, Synairgen, Yuhan.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Astrazeneca, Atyr, CTI Biopharma, Daiichi Sankyo, Hua Medicine, Immutep, Regeneron, Romark, Sanofi, Theravance.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Alexion, Ansun, Astrazeneca, Beigene, Biosig Technologies, Bristol Myers Squibb, Cytodyn, Exelixis, Healios, Incyte, Ipsen, Karyopharm, Novartis, Novavax, Roivant Sciences, Sinovac, Sunovion, Takeda, Viralclear.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Aslan, Bausch Health, Biocryst, Bridge, Eli Lilly, Firstwave, Fujifilm, Kazia, Laurent, Mesoblast, Neuclone, Viriom.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Ansun, Apeiron, Cytodyn, Eusa, Hutchison China Meditech, I-Mab, Inflarx, Inovio, Kiniksa, Nanocarrier, Novan, Oncoceutics, Sato, Synairgen, Vanda, VBL.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Altasciences, Cytodyn, Eagle, Healios, Immutep, Medimetriks, Opthea, Otsuka, Partner, Pluristem, Qurient, Regeneron, Revive, Roivant Sciences, Sanofi, Symbio.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Cytodyn, Genentech, Humanigen, Immutep, Inxmed (Shanghai) Co., Recce.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Moderna, Regeneron, Sanofi, Santen, Takeda, Tracon.